author-photo

Seock-Ah Im

Seoul National University Hospital
Seoul National University

688

Papers

22884

Citations

Citation Trend

Filter By

Papers (688) Sort By

Journal Conference Others

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (33)
Abstract PS11-18: Ceralasertib (cer) in combination with olaparib (ola) in patients (pts) with advanced breast cancer (BC): Results of phase I expansion cohorts

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS3-01: Additional efficacy endpoints from the phase 3 KEYNOTE-355 study of pembrolizumab plus chemotherapy vs placebo plus chemotherapy as first-line therapy for locally recurrent inoperable or metastatic triple-negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.

2021 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (0)
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

2021 Journal of Breast Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PD14-06: Dynamic changes of PD-L1 and T-cell activation in ECLIPSE: A phase II study investigating preoperative immune combination strategies in untreated, operable ER+ primary breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Updated overall survival (OS) results from the phase III MONALEESA-3 trial of postmenopausal patients (pts) with HR+/HER2- advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)